Xp [XP] vs Morgan Stanley [MS] Detailed Stock Comparison

Xp

NASDAQ
Loading...

Morgan Stanley

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Xp wins in 11 metrics, Morgan Stanley wins in 7 metrics, with 0 ties. Xp appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricXpMorgan StanleyBetter
P/E Ratio (TTM)10.1417.83Xp
Price-to-Book Ratio0.412.56Xp
Debt-to-Equity Ratio774.54438.54Morgan Stanley
PEG Ratio0.471.10Xp
EV/EBITDA18.12N/AN/A
Profit Margin (TTM)29.27%22.49%Xp
Operating Margin (TTM)30.54%34.12%Morgan Stanley
EBITDA Margin (TTM)30.54%34.12%Morgan Stanley
Return on Equity23.32%14.13%Xp
Return on Assets (TTM)1.47%1.16%Xp
Free Cash Flow (TTM)$2.04B$-2.10BXp
Dividend Yield3.27%2.15%Xp
1-Year Return-2.39%43.12%Morgan Stanley
Price-to-Sales Ratio (TTM)0.543.83Xp
Enterprise Value$-12.16B$178.59BMorgan Stanley
EV/Revenue Ratio-3.852.72Xp
Gross Profit Margin (TTM)20.56%N/AN/A
Revenue per Share (TTM)$31$41Morgan Stanley
Earnings per Share (Diluted)$1.71$8.84Morgan Stanley
Beta (Stock Volatility)1.111.32Xp
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Xp vs Morgan Stanley Stock Performance Analysis

Loading Price Chart...

Xp
Morgan Stanley
Xp Stock Overview | Morgan Stanley Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Xp-1.27%-10.04%-7.61%-12.11%34.17%44.96%
Morgan Stanley0.32%-1.90%6.25%9.98%56.65%26.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Xp-2.39%-2.62%-59.45%-54.60%-54.60%-54.60%
Morgan Stanley43.12%109.95%204.90%365.66%531.85%202.85%

News Based Sentiment: Xp vs Morgan Stanley

Xp

News based Sentiment: MIXED

The month presented a mixed bag for XP Inc., with a positive revision to the price target from BofA offset by bearish technical indicators and a short-term stock decline. The strong year-to-date outperformance provides a positive counterpoint, but overall the narrative is balanced.

View Xp News Sentiment Analysis

Morgan Stanley

News based Sentiment: MIXED

October was a month of strategic positioning for Morgan Stanley, with expansions into cryptocurrency and investments in advisor education. While analyst sentiment is mixed and institutional ownership shows some bearish signals, the firm is proactively adapting to market changes, making it a significant month for investors to watch.

View Morgan Stanley News Sentiment Analysis

Performance & Financial Health Analysis: Xp vs Morgan Stanley

MetricXPMS
Market Information
Market Cap i$9.54B$251.57B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i6,541,0905,110,020
90 Day Avg. Volume i7,406,9035,282,273
Last Close$17.12$158.09
52 Week Range$10.82 - $20.64$94.33 - $163.98
% from 52W High-17.05%-3.59%
All-Time High$53.08 (Aug 30, 2021)$163.98 (Sep 23, 2025)
% from All-Time High-67.75%-3.59%
Growth Metrics
Quarterly Revenue Growth0.07%0.11%
Quarterly Earnings Growth0.18%0.15%
Financial Health
Profit Margin (TTM) i0.29%0.22%
Operating Margin (TTM) i0.31%0.34%
Return on Equity (TTM) i0.23%0.14%
Debt to Equity (MRQ) i774.54438.54
Cash & Liquidity
Book Value per Share (MRQ)$42.26$61.59
Cash per Share (MRQ)$467.75$352.68
Operating Cash Flow (TTM) i$2.00B$-17,670,000,640
Levered Free Cash Flow (TTM) i$846.98M$12.80B
Dividends
Last 12-Month Dividend Yield i3.27%2.15%
Last 12-Month Dividend i$0.65$2.79

Valuation & Enterprise Metrics Analysis: Xp vs Morgan Stanley

MetricXPMS
Price Ratios
P/E Ratio (TTM) i10.1417.83
Forward P/E i10.3819.87
PEG Ratio i0.471.10
Price to Sales (TTM) i0.543.83
Price to Book (MRQ) i0.412.56
Market Capitalization
Market Capitalization i$9.54B$251.57B
Enterprise Value i$-12,155,760,959$178.59B
Enterprise Value Metrics
Enterprise to Revenue i-3.852.72
Enterprise to EBITDA i18.12N/A
Risk & Other Metrics
Beta i1.111.32
Book Value per Share (MRQ) i$42.26$61.59

Financial Statements Comparison: Xp vs Morgan Stanley

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)XPMS
Revenue/Sales i$336.76M$16.52B
Cost of Goods Sold i$267.52MN/A
Gross Profit i$69.23MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$-225.34MN/A
EBITDA i$-204.67MN/A
Pre-Tax Income i$247.32M$5.54B
Income Tax i$-659,247$1.17B
Net Income (Profit) i$247.98M$4.37B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)XPMS
Cash & Equivalents i$2.27B$60.84B
Total Current Assets i$28.14BN/A
Total Current Liabilities i$35.55BN/A
Long-Term Debt iN/A$303.93B
Total Shareholders Equity i$4.18B$107.85B
Retained Earnings i$479.37M$107.65B
Property, Plant & Equipment i$153.29MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)XPMS
Operating Cash Flow i$40.64M$-67.29B
Capital Expenditures i$-8.11M$-713.00M
Free Cash Flow i$872.58M$-24.69B
Debt Repayment i$-140.65M$-20.85B
Common Stock Repurchase i$-78.26M$-2.03B

Short Interest & Institutional Ownership Analysis

MetricXPMS
Shares Short i22.47M16.22M
Short Ratio i2.803.52
Short % of Float i0.05%0.01%
Average Daily Volume (10 Day) i6,541,0905,110,020
Average Daily Volume (90 Day) i7,406,9035,282,273
Shares Outstanding i100.85M1.61B
Float Shares i422.93M1.21B
% Held by Insiders i0.00%0.24%
% Held by Institutions i0.88%0.63%

Dividend Analysis & Yield Comparison: Xp vs Morgan Stanley

MetricXPMS
Last 12-Month Dividend i$0.65$2.79
Last 12-Month Dividend Yield i3.27%2.15%
3-Year Avg Annual Dividend i$0.65$3.10
3-Year Avg Dividend Yield i3.38%0.90%
3-Year Total Dividends i$1.96$9.31
Ex-Dividend DateDec 10, 2024Jan 31, 2025